These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 12915049)
1. Animal models of stroke: do they have value for discovering neuroprotective agents? Richard Green A; Odergren T; Ashwood T Trends Pharmacol Sci; 2003 Aug; 24(8):402-8. PubMed ID: 12915049 [TBL] [Abstract][Full Text] [Related]
2. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies]. Lestage P; Lockhart B; Roger A Therapie; 2002; 57(6):554-63. PubMed ID: 12666263 [TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke. Savitz SI Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618 [TBL] [Abstract][Full Text] [Related]
5. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Savitz SI; Fisher M Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989 [TBL] [Abstract][Full Text] [Related]
6. Translating promising preclinical neuroprotective therapies to human stroke trials. Cook DJ; Tymianski M Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):433-49. PubMed ID: 21517728 [TBL] [Abstract][Full Text] [Related]
7. The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside. Ntaios G; Savopoulos C; Chatzinikolaou A; Hatzitolios AI Acta Neurol Scand; 2008 Dec; 118(6):362-6. PubMed ID: 18513348 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for the treatment of stroke. Green AR; Shuaib A Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795 [TBL] [Abstract][Full Text] [Related]
9. 1,026 experimental treatments in acute stroke. O'Collins VE; Macleod MR; Donnan GA; Horky LL; van der Worp BH; Howells DW Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316 [TBL] [Abstract][Full Text] [Related]
10. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications. Calabrese EJ Crit Rev Toxicol; 2008; 38(6):557-77. PubMed ID: 18615310 [TBL] [Abstract][Full Text] [Related]
11. Drug repurposing for drug development in stroke. Fagan SC Pharmacotherapy; 2010 Jul; 30(7 Pt 2):51S-4S. PubMed ID: 20575622 [TBL] [Abstract][Full Text] [Related]
12. The past and future of neuroprotection in cerebral ischaemic stroke. Shuaib A; Hussain MS Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451 [TBL] [Abstract][Full Text] [Related]
15. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Philip M; Benatar M; Fisher M; Savitz SI Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479 [TBL] [Abstract][Full Text] [Related]
16. [Past, present and future of neuroprotection]. Mracek J Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585 [TBL] [Abstract][Full Text] [Related]
20. Protecting the brain: the search for a clinically effective neuroprotective drug for stroke. Green AR Crit Rev Neurobiol; 2004; 16(1-2):91-7. PubMed ID: 15581404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]